Glen Eagle Advisors, LLC Becton Dickinson & CO Transaction History

Glen Eagle Advisors, LLC

$593 Billion
Q3 2024

A detailed history of Glen Eagle Advisors, LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 1,153 shares of BDX stock, worth $261,673. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,153

Previous 1,248 7.61%

Holding current value

$261,673

Previous $292 Million 4.67%

% of portfolio

0.05%

Previous 0.05%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$221.47 - $242.41 $21,039 - $23,028	-95 Reduced 7.61%	1,153 $278 Million
Q2 2024 Aug 14, 2024	BUY	$225.07 - $246.17 $138,418 - $151,394	615 Added 97.16%	1,248 $292 Million
Q1 2024 Jul 03, 2024	BUY	$233.45 - $247.73 $291,112 - $308,919	1,247 New	1,247 $309 Million
Q3 2023 Aug 13, 2024	BUY	$254.9 - $283.59 $4,843 - $5,388	19 Added 1.72%	1,124 $291 Million
Q2 2023 Aug 13, 2024	BUY	$238.39 - $265.32 $15,495 - $17,245	65 Added 6.25%	1,105 $292 Million
Q1 2023 Aug 13, 2024	BUY	$229.71 - $259.35 $229 - $259	1 Added 0.1%	1,040 $257 Million
Q4 2022 Aug 13, 2024	BUY	$218.29 - $256.91 $654 - $770	3 Added 0.29%	1,039 $264 Million
Q3 2022 Aug 13, 2024	BUY	$51.03 - $264.23 $255 - $1,321	5 Added 0.48%	1,036 $231 Million
Q2 2022 Aug 13, 2024	BUY	$234.74 - $275.42 $42,018 - $49,300	179 Added 21.01%	1,031 $254 Million
Q4 2021 Aug 13, 2024	BUY	$230.08 - $250.94 $2,300 - $2,509	10 Added 1.19%	852 $214 Million
Q3 2021 Aug 13, 2024	BUY	$232.72 - $256.47 $232 - $256	1 Added 0.12%	842 $207 Million
Q2 2021 Aug 13, 2024	BUY	$232.65 - $254.58 $6,048 - $6,619	26 Added 3.19%	841 $205 Million
Q4 2020 Aug 13, 2024	SELL	$221.92 - $245.94 $95,869 - $106,246	-432 Reduced 34.64%	815 $204 Million
Q3 2020 Aug 13, 2024	SELL	$215.77 - $276.76 $30,207 - $38,746	-140 Reduced 14.66%	815 $190 Million
Q2 2020 Aug 13, 2024	BUY	$219.9 - $263.41 $1,319 - $1,580	6 Added 0.63%	955 $229 Million
Q1 2020 Aug 13, 2024	BUY	$195.69 - $279.01 $17,612 - $25,110	90 Added 10.48%	949 $218 Million
Q4 2019 Aug 13, 2024	BUY	$236.45 - $266.82 $53,437 - $60,301	226 Added 35.7%	859 $234 Million
Q1 2019 Aug 13, 2024	SELL	$206.05 - $248.17 $126,514 - $152,376	-614 Reduced 49.24%	633 $158 Million
Q1 2018 Aug 14, 2024	SELL	$205.46 - $240.27 $126,152 - $147,525	-614 Reduced 49.24%	633 $137 Million
Q1 2018 Aug 13, 2024	BUY	$205.46 - $240.27 $20,546 - $24,027	100 Added 18.76%	633 $137 Million
Q3 2017 Aug 13, 2024	SELL	$186.89 - $198.9 $133,439 - $142,014	-714 Reduced 57.26%	533 $104 Million
Q2 2017 Aug 12, 2024	SELL	N/A	-9 Reduced 1.62%	545 $106 Million
Q4 2016 Aug 12, 2024	SELL	N/A	-693	554 $91.7 Million

Others Institutions Holding BDX

# of Institutions

1,738

Shares Held

249M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64.7B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glen Eagle Advisors, LLC with notifications on news.

Account

Glen Eagle Advisors, LLC Becton Dickinson & CO Transaction History